Barr Would Share Generic Provigil Exclusivity Under FDA’s Revised Guidelines
Executive Summary
Barr would share exclusivity for its generic version of Cephalon's narcolepsy agent Provigil (modafinil) with three other generic companies under FDA's new guidance redefining "first-to-file" status